TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive Shubik Subcommittee Criticizes New Study Section, Asks NCI To Hire More Epidemiologists December 5, 1975